Clinical Trial Update: Assessing Immunogenicity of Intramuscular Sabin Inactivated Poliovirus Vaccine and Non-inferiority of Intradermal Fractional Inactivated Poliovirus Vaccine [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update assessing immunogenicity of intramuscular Sabin Inactivated Poliovirus Vaccine (sIPV) and non-inferiority of an intradermal frac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• Intradermal Fractional Inactivated Poliovirus Vaccine (fractional intradermal inactivated poliovirus vaccine)
• Sabin Inactivated Poliovirus Vaccine (inactivated poliovirus vaccine (Sabin strain))

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Poliomyelitis | Phase 4 | Status: COMPLETED